NYSE ARCA | ETF
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy.
It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index.
The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI).
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| CYTK | Cytokinetics Inc | Healthcare | Biotechnology | 2.74% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 1.77% |
| ARWR | Arrowhead Pharmaceuticals Inc | Healthcare | Biotechnology | 1.64% |
| ACAD | ACADIA Pharmaceuticals Inc | Healthcare | Biotechnology | 1.59% |
| ARDX | Ardelyx Inc | Healthcare | Biotechnology | 1.55% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 1.52% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 1.46% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 1.44% |
| RXRX | Recursion Pharmaceuticals Inc | Healthcare | Biotechnology | 1.39% |
| KRYS | Krystal Biotech Inc | Healthcare | Biotechnology | 1.37% |
| MDGL | Madrigal Pharmaceuticals Inc | Healthcare | Biotechnology | 1.35% |
| IOVA | Iovance Biotherapeutics Inc | Healthcare | Biotechnology | 1.34% |
| BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 1.33% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.30% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 1.30% |
| FOLD | Amicus Therapeutics Inc | Healthcare | Biotechnology | 1.30% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 1.29% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 1.28% |
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 1.28% |
| AKRO | Akero Therapeutics Inc | Healthcare | Biotechnology | 1.27% |